Kanhaiya Singhal
Tracked across 3 events · 23 articles · First seen Jan 19, 2026 · Last active Jun 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Kanhaiya Singhal, Executive Vice President and Head of Development at Biogen, expressed confidence that RayThera's programs will contribute meaningfully to Biogen's long-term pipeline potential.
Jun 17, 2026 · 10 articles
Domestic
Impact: Kanhaiya Singhal, advocate for Kuldeep Singh Sengar, supported the arguments for his bail, but the plea was rejected.
Jan 19, 2026 · 6 articles
Tech
Impact: Kanhaiya Singhal, Executive Vice President and Head of Development at Biogen, expressed excitement about the CELIA study results and the plan to advance diranersen.
May 14, 2026 · 7 articles
NEWSDESK
Track Kanhaiya Singhal live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard